Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $37.91 million. The enterprise value is $40.84 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, after market close.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 5.86 million shares outstanding. The number of shares has increased by 76.77% in one year.
| Current Share Class | 5.86M |
| Shares Outstanding | 5.86M |
| Shares Change (YoY) | +76.77% |
| Shares Change (QoQ) | +43.45% |
| Owned by Insiders (%) | 2.29% |
| Owned by Institutions (%) | 43.71% |
| Float | 4.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | 0.82 |
| PB Ratio | -0.39 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.48
| Current Ratio | 0.48 |
| Quick Ratio | 0.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -35.66% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 307.47% |
| Revenue Per Employee | $842,745 |
| Profits Per Employee | -$558,190 |
| Employee Count | 153 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 16.58 |
Taxes
| Income Tax | -12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.16% in the last 52 weeks. The beta is 0.30, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -51.16% |
| 50-Day Moving Average | 6.71 |
| 200-Day Moving Average | 8.86 |
| Relative Strength Index (RSI) | 44.08 |
| Average Volume (20 Days) | 48,089 |
Short Selling Information
The latest short interest is 522,139, so 8.91% of the outstanding shares have been sold short.
| Short Interest | 522,139 |
| Short Previous Month | 662,188 |
| Short % of Shares Out | 8.91% |
| Short % of Float | 12.43% |
| Short Ratio (days to cover) | 12.61 |
Income Statement
In the last 12 months, ATRA had revenue of $128.94 million and -$85.40 million in losses. Loss per share was -$11.41.
| Revenue | 128.94M |
| Gross Profit | -39.80M |
| Operating Income | -78.33M |
| Pretax Income | -233.09M |
| Net Income | -85.40M |
| EBITDA | -73.28M |
| EBIT | -78.33M |
| Loss Per Share | -$11.41 |
Full Income StatementBalance Sheet
The company has $42.50 million in cash and $45.43 million in debt, giving a net cash position of -$2.94 million or -$0.50 per share.
| Cash & Cash Equivalents | 42.50M |
| Total Debt | 45.43M |
| Net Cash | -2.94M |
| Net Cash Per Share | -$0.50 |
| Equity (Book Value) | -97.28M |
| Book Value Per Share | -16.60 |
| Working Capital | -69.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$68.72 million and capital expenditures -$246,000, giving a free cash flow of -$68.96 million.
| Operating Cash Flow | -68.72M |
| Capital Expenditures | -246,000 |
| Free Cash Flow | -68.96M |
| FCF Per Share | -$11.77 |
Full Cash Flow StatementMargins
Gross margin is -30.87%, with operating and profit margins of -60.75% and -66.23%.
| Gross Margin | -30.87% |
| Operating Margin | -60.75% |
| Pretax Margin | -66.24% |
| Profit Margin | -66.23% |
| EBITDA Margin | -56.83% |
| EBIT Margin | -60.75% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.77% |
| Shareholder Yield | -76.77% |
| Earnings Yield | -225.30% |
| FCF Yield | -181.93% |
Analyst Forecast
The average price target for ATRA is $17.75, which is 174.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.75 |
| Price Target Difference | 174.34% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -2.74% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04:1.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04:1 |
Scores
ATRA has an Altman Z-Score of -28.14 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.14 |
| Piotroski F-Score | 3 |